Nicolet Bankshares Inc Biogen Inc. Transaction History

Nicolet Bankshares Inc

$488 Million
Q3 2024

A detailed history of Nicolet Bankshares Inc transactions in Biogen Inc. stock. As of the latest transaction made, Nicolet Bankshares Inc holds 1,476 shares of BIIB stock, worth $235,909. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,476

Previous 1,559 5.32%

Holding current value

$235,909

Previous $361,000 20.78%

% of portfolio

0.06%

Previous 0.08%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$189.07 - $236.8 $15,692 - $19,654	-83 Reduced 5.32%	1,476 $286,000
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $292,448 - $363,365	-1,535 Reduced 49.61%	1,559 $361,000
Q1 2024 May 09, 2024	BUY	$212.02 - $267.71 $6,784 - $8,566	32 Added 1.05%	3,094 $667,000
Q4 2023 Feb 13, 2024	BUY	$222.59 - $267.94 $69,225 - $83,329	311 Added 11.3%	3,062 $792,000
Q3 2023 Nov 09, 2023	SELL	$253.3 - $285.89 $331,823 - $374,515	-1,310 Reduced 32.26%	2,751 $707,000
Q2 2023 Aug 09, 2023	BUY	$275.25 - $318.06 $421,132 - $486,631	1,530 Added 60.45%	4,061 $1.16 Million
Q1 2023 May 09, 2023	BUY	$256.56 - $292.34 $2,052 - $2,338	8 Added 0.32%	2,531 $703,000
Q4 2022 Feb 09, 2023	BUY	$252.44 - $306.72 $337,007 - $409,471	1,335 Added 112.37%	2,523 $698,000
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $231,291 - $318,930	1,188 New	1,188 $317,000
Q3 2021 Nov 16, 2021	SELL	$282.99 - $369.05 $251,295 - $327,716	-888 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$259.0 - $414.71 $29,785 - $47,691	-115 Reduced 11.47%	888 $307,000
Q4 2020 Feb 02, 2021	SELL	$236.26 - $355.63 $5,906 - $8,890	-25 Reduced 2.43%	1,003 $246,000
Q2 2020 Jul 22, 2020	SELL	$258.66 - $342.55 $158,817 - $210,325	-614 Reduced 37.39%	1,028 $275,000
Q1 2020 Apr 22, 2020	SELL	$268.85 - $341.04 $6,183 - $7,843	-23 Reduced 1.38%	1,642 $519,000
Q4 2019 Jan 24, 2020	SELL	$220.06 - $304.07 $9,682 - $13,379	-44 Reduced 2.57%	1,665 $494,000
Q3 2019 Oct 22, 2019	SELL	$217.44 - $243.88 $3,479 - $3,902	-16 Reduced 0.93%	1,709 $398,000
Q2 2019 Jul 30, 2019	SELL	$219.29 - $241.72 $4,166 - $4,592	-19 Reduced 1.09%	1,725 $403,000
Q1 2019 Apr 26, 2019	SELL	$216.71 - $338.96 $433 - $677	-2 Reduced 0.11%	1,744 $412,000
Q4 2018 Feb 06, 2019	SELL	$278.5 - $352.75 $1,949 - $2,469	-7 Reduced 0.4%	1,746 $525,000
Q3 2018 Oct 29, 2018	SELL	$293.51 - $383.83 $123,567 - $161,592	-421 Reduced 19.37%	1,753 $619,000
Q2 2018 Jul 31, 2018	SELL	$257.52 - $306.91 $19,571 - $23,325	-76 Reduced 3.38%	2,174 $631,000
Q1 2018 May 03, 2018	BUY	$260.13 - $367.91 $3,641 - $5,150	14 Added 0.63%	2,250 $616,000
Q4 2017 Feb 02, 2018	SELL	$307.64 - $344.58 $25,534 - $28,600	-83 Reduced 3.58%	2,236 $712,000
Q3 2017 Nov 02, 2017	BUY	$281.15 - $329.69 $651,986 - $764,551	2,319	2,319 $726,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicolet Bankshares Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nicolet Bankshares Inc with notifications on news.

Account

Nicolet Bankshares Inc Biogen Inc. Transaction History